MARGARET CLAIRE DEROOS

INDIANAPOLIS, IN

This page merges CMS profile IDs: 11254015, 11389504 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$715.43

  • Category: General Payments
  • Program years: PY2021–2023
  • Record count: 39
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $360.29 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $360.2918

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $116.206
Novo Nordisk AS $85.544
ABBVIE INC. $64.433
Acerta Pharma LLC $45.662
Exact Sciences Corporation $17.151
Medtronic, Inc. $17.061
PFIZER INC. $14.251

By program year

Program yearAmountRecords
2021 $193.0011
2022 $162.1410
2023 $360.2918

Records — PY2023 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1002945291 Novo Nordisk Inc $17.59 09/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002945303 Novo Nordisk Inc $21.02 07/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002945315 Novo Nordisk Inc $21.93 04/18/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002945323 Novo Nordisk Inc $25.00 02/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011507247 AstraZeneca Pharmaceuticals LP $26.76 09/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015948117 AstraZeneca Pharmaceuticals LP $18.90 08/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1019451333 Medtronic, Inc. $17.06 07/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1027391865 Exact Sciences Corporation $17.15 01/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031791453 Lilly USA, LLC $17.08 01/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031795067 Lilly USA, LLC $20.96 05/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031795071 Lilly USA, LLC $18.68 02/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031806547 Lilly USA, LLC $15.23 04/04/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031885913 Lilly USA, LLC $23.80 05/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031909965 Lilly USA, LLC $20.45 05/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050571771 PFIZER INC. $14.25 06/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996646881 AbbVie Inc. $24.52 06/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996646885 AbbVie Inc. $15.27 08/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996646889 AbbVie Inc. $24.64 08/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
  • Merged CMS profile IDs: 11254015, 11389504

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.